DuoResp Spiromax (budesonide/formoterol) / Teva  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DuoResp Spiromax (budesonide/formoterol) / Teva
2021-003951-41: A Study to Test if Using the BF Digihaler System is Effective in Getting Better Control of Asthma in Adult Patients Compared to Usual Care

Not yet recruiting
4
500
Europe
Budesonide/Formoterol Digihaler Digital System, ICS/LABA combinations, NA, Inhalation powder, Inhalation solution, ICS/LABA combinations
Teva Branded Pharmaceutical Products R&D, Inc., Teva Branded Pharmaceutical
Asthma, Asthma, Diseases [C] - Respiratory Tract Diseases [C08]
 
 

Download Options